InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
7
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-2.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Legorreta Pablo G., Director. Director active across 3 companies, notably Royalty Pharma plc. Cumulatively, 17 disclosures have been published. Split: 7 buys · 0 sell. Total volume traded: €126.3m. Activity tracked since 7 May 2021. The latest transaction was filed on 16 May 2025 (J). Regulator: SEC (Form 4). All data is openly available.
Declarations17 total
530,348 shares0Class A Ordinary SharesSEC:0001802768-25-000063:0
288,352 shares0Class A Ordinary SharesSEC:0001802768-25-000039:0
532,535 shares0Class A Ordinary SharesSEC:0000950170-25-015495:0
22,617,909 shares@ US$2.42100.0% of flowClass A Ordinary SharesSEC:0000950170-24-073633:0
Ideal exit: 10 Mar 2025 (T+270)
748,952 shares0Class A Ordinary SharesSEC:0000950170-24-011711:0
292,190.49 shares0Class A ordinary sharesSEC:0000950103-23-016404:0
5,289,055 shares0Class A Ordinary SharesSEC:0001209191-23-054044:0
130,000 shares@ US$29.513624.5% of flowClass A ordinary sharesSEC:0001209191-23-040024:0
Ideal exit: 24 Mar 2024 (T+270)
45,000 shares@ US$32.99889.6% of flowClass A ordinary sharesSEC:0001209191-23-036624:0
Ideal exit: 8 Mar 2024 (T+270)
150,000 shares@ US$32.249631.3% of flowClass A ordinary sharesSEC:0000950103-23-007785:0
Ideal exit: 18 Feb 2024 (T+270)
160,388 shares@ US$33.566934.5% of flowClass A ordinary sharesSEC:0000950103-23-007427:0
Ideal exit: 10 Feb 2024 (T+270)
31,933,334 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028860:0
493,750 shares0Class A Ordinary SharesSEC:0000950103-22-006475:0
22,666,667 shares@ US$1.5050.0% of flowCommon StockSEC:0000899243-22-003857:0
Ideal exit: 28 Oct 2022 (T+270)
22,666,667 shares@ US$1.50100.0% of flowCommon StockSEC:0000899243-22-003857
Ideal exit: 28 Oct 2022 (T+270)
1,040,410 shares0Class A Ordinary SharesSEC:0000950103-21-007075
1,040,410 shares0Class A Ordinary SharesSEC:0000950103-21-007075:0
17 of 17 declarations
About Legorreta Pablo G.
Pablo G. Legorreta is the CEO, Chairman of the Board, and Board Member at Royalty Pharma plc and Epizyme, Inc. He is responsible for the strategic direction of these companies, ensuring alignment of operations with overall objectives. His leadership and vision are essential in guiding these organizations through a competitive landscape.
